Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-30
2011-08-30
Seaman, D M (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S121000
Reexamination Certificate
active
08008321
ABSTRACT:
The invention concerns compounds of formula I, a method for preparing said compounds, pharmaceutical compositions containing same and the therapeutic uses thereof.
REFERENCES:
patent: 2005/0203126 (2005-09-01), Badorc et al.
patent: 2009/0069368 (2009-03-01), Bono et al.
patent: WO 03/084956 (2003-10-01), None
International Search Report dated Jul. 25, 2006.
Thompson, et al., 3-(3,5-Dimethoxyphenyl)-1, 6-Naphthyridine-2,7-diamines and related 2-urea derivatives of the FGF receptor-1 tyrosine kinase, J. of Med. Chem.; vol. 43; No. 22; pp. 4200-4211, (2000).
Alcouffe Chantal
Badorc Alain
Bono Francoise
Bordes Marie-Francoise
Rahmani Niloofar
Sanofi-Aventis
Scully , Scott, Murphy & Presser, P.C.
Seaman D M
LandOfFree
Imidazo[1,5-a] pyridine derivatives, method for preparing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazo[1,5-a] pyridine derivatives, method for preparing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazo[1,5-a] pyridine derivatives, method for preparing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2695287